Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580) |
---|
01/24/2002 | WO2001081291A3 The oxidation of ketones to esters using a tin substituted zeolite beta |
01/24/2002 | US20020010204 Use as pesticides. |
01/24/2002 | DE10033459A1 New aminomethyl-substituted bicyclic compounds, useful for treating urinary incontinence, pruritis, tinnitus, diarrhea or especially pain |
01/10/2002 | US20020004522 Nervous system disorders |
01/08/2002 | US6337410 Antibiotic TKR459, production method, and microorganism |
01/03/2002 | US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
12/27/2001 | US20010056093 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
12/26/2001 | CN1076587C Process for preparing natural bud inhibitor and its application in inhibiting axillary bud of tobacco |
12/25/2001 | US6333349 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
12/25/2001 | US6333329 Useful for treatment and/or prevention of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, drug abuse, parkinson-like motor disorders and motion disorders |
12/12/2001 | EP0788356B1 Method and compositions for inhibiting protein kinases |
12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
11/29/2001 | US20010046982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
11/28/2001 | EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof |
11/27/2001 | US6323347 Used for dehydrocyclization reaction of a diol under a gas phase to form lactone; activity, long lifetime and high selectivity of products |
11/27/2001 | US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative |
11/14/2001 | EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors |
11/14/2001 | EP1153022A1 Prothease inhibitors |
11/13/2001 | US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone |
11/13/2001 | US6316491 Radicicol derivatives |
11/08/2001 | WO2001083800A2 Heterologous production of polyketides |
11/08/2001 | WO2001032644A3 Excitatory amino acid derivatives |
11/01/2001 | WO2001081291A2 The oxidation of ketones to esters using a tin substituted zeolite beta |
10/25/2001 | US20010034452 Epothilons C and D, preparation and compositions |
10/23/2001 | US6307067 Palladium and boron co-catalyzed addition of oxygen nucleophiles to vinyl epoxides |
10/23/2001 | US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
10/23/2001 | CA2004471C Direct fluorination process for making perfluorinated organic substances |
10/18/2001 | US20010031786 Antidiabetic agents, obesity |
10/18/2001 | US20010031764 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
10/18/2001 | US20010031762 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
10/11/2001 | US20010029256 Peroxisome proliferator activator receptor; dietetics, antidiabetic agents |
10/10/2001 | EP1141358A1 ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA |
10/10/2001 | EP1140893A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
10/10/2001 | EP1140791A2 Selective cpla 2 inhibitors |
10/10/2001 | EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
10/10/2001 | EP0840731B1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists |
10/10/2001 | CN1072665C Preparation of unsaturated cyclic ethers |
10/09/2001 | US6300355 For therapy of cancer |
10/04/2001 | US20010027208 A 2-oxime derivative; antitumor and -carcinogenic agents; immunosuppressents; osteoporosis; enzyme inhibitors of tyrosine kinase activity |
09/26/2001 | EP1135470A2 Recombinant methods and materials for producing epothilone and epothilone derivatives |
09/26/2001 | CN1314881A Imidamide derivatives |
09/20/2001 | WO2001068636A1 Method for carrying out a baeyer-villiger oxidation of organic carbonyl compounds |
09/20/2001 | DE10012340A1 Baeyer-Villiger oxidation of organic carbonyl compounds comprises reacting a carbonyl compound(s) with an oxidation agent(s) in a microreactor(s) and optionally isolating |
09/18/2001 | US6291399 Agent for controlling diseases and insect pests, containing alkoxyimino-substituted bicyclic derivative as active ingredient |
09/13/2001 | WO2001066501A1 Process for the preparation of organic compounds with manganese catalysts or the like |
09/13/2001 | WO2001009138A3 Chemokine receptor antagonists and methods of use therefor |
09/13/2001 | US20010021520 2,4,5-trihydroxy-1-amino pyran derivative used as antifungal agent formed by cultivating a strain of microorganism belonging to the class Fungi Imperfecti; active against Candida albicans, Cryptococcus neoformans and Candida kefyr |
09/11/2001 | US6288237 Plant protection. immunosuppression and/or be used to combat malignant tumours; they are particularily preferred as cytostatic agents. |
09/05/2001 | EP1129068A1 Bicyclic signal transduction inhibitors, composition containing them and uses thereof |
09/04/2001 | US6284900 Cis-isoambrettolide of high degree of isomer purity and use thereof |
09/04/2001 | US6284781 Anticancer agent |
08/30/2001 | US20010018399 Composition comprising antimony trifluoride and silica |
08/29/2001 | EP0892772B1 A process for the preparation of calixarenes |
08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
08/28/2001 | US6281365 (Gem-heterocyclodimethanamine-n,n′)platinum complexes |
08/28/2001 | US6280898 Photoresists patterns |
08/23/2001 | WO2001060768A1 Process for producing cyclic compound |
08/23/2001 | CA2400979A1 Process for producing cyclic compound |
08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
08/16/2001 | EP1123269A1 New compounds, their preparation and use |
08/16/2001 | EP1123268A1 New compounds, their preparation and use |
08/16/2001 | EP1123267A1 New compounds, their preparation and use |
08/14/2001 | US6274560 Incubating diketide with modified polyketide synthase; recovering; genetic engineering |
08/09/2001 | WO2001057015A1 INTERNAL 1,15-LACTONES OF FLUPROSTENOL AND RELATED PROSTAGLANDIN F2α ANALOGS AND THEIR USE IN THE TREATMENT OF GLAUCOMA AND INTRAOCULAR HYPERTENSION |
08/08/2001 | EP1121980A1 Composition comprising antimony trifluoride and silica |
08/08/2001 | CN1307571A Guanidine derivatives |
08/08/2001 | CN1307553A Process for solid phase synthesis of aldehyde ketone oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
08/02/2001 | WO2001055129A1 Synthesis of macrocyclic monomers |
08/02/2001 | WO2001054687A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
08/02/2001 | DE10003435A1 Synthese von makrocyclischen Monomeren Synthesis of macrocyclic monomers |
08/01/2001 | EP1037627B1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
08/01/2001 | CN1306531A Epothilones derivatives, their synthesis and uses |
07/31/2001 | US6268354 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
07/26/2001 | WO1999015129A3 SELECTIVE cPLA2 INHIBITORS |
07/26/2001 | US20010009964 Catalyst for preparing lactone and a method for preparing lactone |
07/11/2001 | EP1019042A4 Anti-first-pass effect compounds |
07/10/2001 | CA2059792C Tricyclic compounds and intermediates thereof |
07/05/2001 | WO2001047889A1 Tricyclic compounds |
07/05/2001 | WO2001009094A3 Chemokine receptor antagonists and methods of use therefor |
07/05/2001 | CA2395834A1 Tricyclic compounds |
07/04/2001 | EP1112240A1 The addition of oxygen nucleophiles to vinyl epoxides |
07/03/2001 | US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
07/03/2001 | US6255342 Pesticides |
07/03/2001 | US6255276 Odorant compositions containing macrocycles and processes for manufacturing the same |
06/28/2001 | US20010005753 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands |
06/27/2001 | EP0797564B1 Lignans, a process for their production and pharmaceutical compositions and uses thereof |
06/19/2001 | US6248781 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
06/14/2001 | WO2001009113A3 Heterocyclic compounds inhibiting angiogenesis |
06/06/2001 | EP1104416A2 Quaternary ammonium salts and their use as anti-hiv agents |
06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
06/05/2001 | US6242469 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
05/29/2001 | US6239171 Tocotrienols and tocotrienol-like compounds and methods for their use |
05/29/2001 | US6239168 Antitumor agents, immunosuppressants; tyrosine kinase inhibitors |
05/29/2001 | US6239073 Brassinosteroid analogs useful as plant growth regulators |
05/23/2001 | CN1296480A Process for preparation of esters or lactones |
05/17/2001 | WO2001014360A3 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |